Medtech Adapts to Tariffs
A year after renewed trade disruptions, medtech firms are proactively changing sourcing and cost structures rather than simply absorbing tariff pain. Analysts warn the shift could keep cost volatility in the supply chain and affect equipment pricing, parts availability and replacement timing for imaging operators. (healthcaredive.com) (rbc.com)
A tariff is basically a tax at the border, and for a hospital scanner that can mean the bill jumps before the crate is even opened. One year after President Donald Trump’s April 2, 2025 “Liberation Day” tariff rollout, medical technology companies are no longer treating that jump as a temporary headache. (medtechdive.com) What changed is the response. Instead of simply eating the cost or immediately charging hospitals more, many device makers are cutting expenses elsewhere, rewriting supplier contracts, and changing where parts come from so tariff costs do not flow straight into earnings. (medtechdive.com) That is harder in medical technology than in some other industries because a scanner, infusion pump, or surgical tool is built from parts sourced across several countries. MedTech Dive says the sector’s supply chains were built for efficiency over years, so moving production is slower than flipping a switch in a factory. (medtechdive.com) The United States also imports a lot of this equipment. A November 2025 analysis from the University of North Carolina’s Center for the Business of Health says 62% of medical devices used in the United States are imported, mainly from Europe, Mexico, and China. (cboh.kenaninstitute.unc.edu) That import dependence turns a trade policy fight into a hospital budgeting problem. The same University of North Carolina analysis says current tariffs on medical devices range from 10% to 50% depending on where the product was made. (cboh.kenaninstitute.unc.edu) For the biggest manufacturers, the numbers are already large enough to change strategy. MedTech Dive reports that advisers tracking the sector see annual tariff hits of roughly $200 million to $500 million for some individual companies. (medtechdive.com) Siemens Healthineers, one of the world’s biggest imaging vendors, said in November 2025 that tariffs that cost 200 million euros in fiscal 2025 were expected to cost 400 million euros in fiscal 2026. In February 2026, the company said it was still dealing with tariff and currency pressure at the start of the new fiscal year. (medtechdive.com) (siemens-healthineers.com) Johnson & Johnson gave the same kind of warning from a different corner of the device market. In April 2025, the company said worldwide tariffs would create an approximately $400 million charge for the year, with the medical technology division taking most of the hit. (medtechdive.com) The catch is that companies can dodge a tariff in one place and create volatility in another. Royal Bank of Canada wrote this week that 2025 tariffs reshuffled where United States imports came from rather than simply crushing trade, with more sourcing shifting toward countries like Vietnam, Taiwan, and Thailand. (rbc.com) For imaging departments, that can show up as higher quotes, longer waits for replacement parts, or a decision to keep an older machine running for another year. Hospital advisers told providers in 2025 that tariff-driven replacement costs could push systems to extend the useful life of imaging and diagnostic equipment beyond normal depreciation schedules. (vmghealth.com) So the story a year later is not that medtech found a clean workaround. It is that device makers are turning tariffs into a permanent operating variable, and hospitals may feel that in equipment pricing, service timing, and how long aging scanners stay on the floor. (medtechdive.com) (cboh.kenaninstitute.unc.edu)
